April 11, 2025 - 20:08

John Coogan and Jordi Hays have unveiled "TBPN," a fresh daily tech show that is quickly capturing the attention of tech enthusiasts and industry insiders alike. This innovative platform focuses on the journeys of startup founders and venture capitalists, offering listeners an inside look at the rapidly evolving world of technology and entrepreneurship.
With a unique blend of insightful interviews and engaging discussions, Coogan and Hays aim to bridge the gap between aspiring entrepreneurs and seasoned investors. Each episode features in-depth conversations that delve into the challenges and triumphs faced by those at the forefront of innovation. The show not only highlights emerging technologies but also provides valuable advice for those looking to navigate the complex landscape of the tech industry.
As "TBPN" continues to grow in popularity, it stands out among a sea of tech podcasts by emphasizing real stories and practical insights. With their passion for technology and commitment to fostering connections, Coogan and Hays are poised to make a significant impact on the tech podcasting landscape.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...